All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| WVE / Wave Life Sciences Ltd.
|
|
|
|
|
|
|
|
| RVMD / Revolution Medicines, Inc.
|
|
|
|
|
|
|
|
| BBIO / BridgeBio Pharma, Inc.
|
|
|
|
|
|
|
|
| SPY / SPDR S&P 500 ETF Put
|
|
|
|
|
|
|
|
| TERN / Terns Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| CTNM / Contineum Therapeutics, Inc.
|
|
|
|
|
|
|
|
| HIMS / Hims & Hers Health, Inc. Call
|
|
|
|
|
|
|
|
| INCY / Incyte Corporation
|
|
|
|
|
|
|
|
| SRPT / Sarepta Therapeutics, Inc.
|
|
|
|
|
|
|
|
| KALV / KalVista Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| CAPR / Capricor Therapeutics, Inc.
|
|
|
|
|
|
|
|
| RCKT / Rocket Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| MRUS / Merus N.V.
|
|
|
|
|
|
|
|
| IMVT / Immunovant, Inc. Call
|
|
|
|
|
|
|
|
| ACLX / Arcellx, Inc.
|
|
|
|
|
|
|
|
| PCSC / Perceptive Capital Solutions Corp
|
|
|
|
|
|
|
|
| IMVT / Immunovant, Inc.
|
|
|
|
|
|
|
|
| JANX / Janux Therapeutics, Inc.
|
|
|
|
|
|
|
|
| QQQ / Invesco QQQ Trust, Series 1 Put
|
|
|
|
|
|
|
|
| ALKS / Alkermes plc
|
|
|
|
|
|
|
|
| SNDX / Syndax Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| IOVA / Iovance Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
| ROIV / Roivant Sciences Ltd.
|
|
|
|
|
|
|
|
| SRRK / Scholar Rock Holding Corporation
|
|
|
|
|
|
|
|
| TRML / Tourmaline Bio, Inc.
|
|
|
|
|
|
|
|
| DNLI / Denali Therapeutics Inc.
|
|
|
|
|
|
|
|
| NUVL / Nuvalent, Inc.
|
|
|
|
|
|
|
|
| ETNB / 89bio, Inc.
|
|
|
|
|
|
|
|
| BHVN / Biohaven Ltd.
|
|
|
|
|
|
|
|
| CRNX / Crinetics Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| JSPR / Jasper Therapeutics, Inc.
|
|
|
|
|
|
|
|
| EYPT / EyePoint Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| SLRN / Acelyrin, Inc.
|
|
|
|
|
|
|
|
| RYTM / Rhythm Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| SRZN / Surrozen, Inc.
|
|
|
|
|
|
|
|
| TCRX / TScan Therapeutics, Inc.
|
|
|
|
|
|
|
|
| AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| DAWN / Day One Biopharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| IMTX / Immatics N.V.
|
|
|
|
|
|
|
|
| NGNE / Neurogene Inc.
|
|
|
|
|
|
|
|
| ZURA / Zura Bio Limited
|
|
|
|
|
|
|
|
| PYXS / Pyxis Oncology, Inc.
|
|
|
|
|
|
|
|
| CATX / Perspective Therapeutics, Inc.
|
|
|
|
|
|
|
|
| NRIX / Nurix Therapeutics, Inc.
|
|
|
|
|
|
|
|
| APLT / Applied Therapeutics, Inc. Call
|
|
|
|
|
|
|
|
| APLT / Applied Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ATXS / Astria Therapeutics, Inc.
|
|
|
|
|
|
|
|
| VIGL / Vigil Neuroscience, Inc.
|
|
|
|
|
|
|
|
| PRAX / Praxis Precision Medicines, Inc.
|
|
|
|
|
|
|
|
| CABA / Cabaletta Bio, Inc.
|
|
|
|
|
|
|
|
| BNTX / BioNTech SE - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| CYTK / Cytokinetics, Incorporated
|
|
|
|
|
|
|
|
| KROS / Keros Therapeutics, Inc.
|
|
|
|
|
|
|
|
| MLYS / Mineralys Therapeutics, Inc.
|
|
|
|
|
|
|
|
| VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| TARA / Protara Therapeutics, Inc.
|
|
|
|
|
|
|
|
| FOLD / Amicus Therapeutics, Inc.
|
|
|
|
|
|
|
|
| URGN / UroGen Pharma Ltd.
|
|
|
|
|
|
|
|
| BMY / Bristol-Myers Squibb Company
|
|
|
|
|
|
|
|
| ARQT / Arcutis Biotherapeutics, Inc. Call
|
|
|
|
|
|
|
|
| MBX / MBX Biosciences, Inc.
|
|
|
|
|
|
|
|
| CDTX / Cidara Therapeutics, Inc.
|
|
|
|
|
|
|
|
| PTGX / Protagonist Therapeutics, Inc.
|
|
|
|
|
|
|
|
| INSM / Insmed Incorporated
|
|
|
|
|
|
|
|
| SNDX / Syndax Pharmaceuticals, Inc. Call
|
|
|
|
|
|
|
|
| CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| ARQT / Arcutis Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
| HLXB / Helix Acquisition Corp. II
|
|
|
|
|
|
|
|
| IDYA / IDEAYA Biosciences, Inc.
|
|
|
|
|
|
|
|
| QURE / uniQure N.V.
|
|
|
|
|
|
|
|
| EWTX / Edgewise Therapeutics, Inc.
|
|
|
|
|
|
|
|
| LIFE / aTyr Pharma, Inc.
|
|
|
|
|
|
|
|
| NMRA / Neumora Therapeutics, Inc.
|
|
|
|
|
|
|
|
| TECX / Tectonic Therapeutic, Inc.
|
|
|
|
|
|
|
|
| SRRK / Scholar Rock Holding Corporation Call
|
|
|
|
|
|
|
|
| ELVN / Enliven Therapeutics, Inc.
|
|
|
|
|
|
|
|
| SLNO / Soleno Therapeutics, Inc.
|
|
|
|
|
|
|
|
| VTGN / Vistagen Therapeutics, Inc.
|
|
|
|
|
|
|
|
| RARE / Ultragenyx Pharmaceutical Inc.
|
|
|
|
|
|
|
|
| XENE / Xenon Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
